Email This Press Releases

NASDAQ:CCXI Investor Notice: Lawsuit Alleges Misleading Statements by ChemoCentryx, Inc.

An investor, who purchased NASDAQ:CCXI shares, filed a lawsuit against ChemoCentryx, Inc. over alleged violations of Federal Securities Laws.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy